| Literature DB >> 29649747 |
Jaydev R Upponi1, Kaushal Jerajani1, Dattatri K Nagesha2, Praveen Kulkarni3, Srinivas Sridhar2, Craig Ferris3, Vladimir P Torchilin4.
Abstract
Interest in theranostic agents has continued to grow because of their promise for simultaneous cancer detection and therapy. A platform-based nanosized combination agent suitable for the enhanced diagnosis and treatment of cancer was prepared using polymeric polyethylene glycol-phosphatidylethanolamine-based micelles loaded with both, poorly soluble chemotherapeutic agent paclitaxel and hydrophobic superparamagnetic iron oxide nanoparticles (SPION), a Magnetic Resonance Imaging contrast agent. The co-loaded paclitaxel and SPION did not affect each other's functional properties in vitro. In vivo, the resulting paclitaxel-SPION-co-loaded PEG-PE micelles retained their Magnetic Resonance contrast properties and apoptotic activity in breast and melanoma tumor mouse models. Such theranostic systems are likely to play a significant role in the combined diagnosis and therapy that leads to a more personalized and effective form of treatment.Entities:
Keywords: Cancer therapy; Diagnostics; Drug delivery; Micelles; Nanoparticles; Theranostics
Mesh:
Substances:
Year: 2018 PMID: 29649747 PMCID: PMC5918157 DOI: 10.1016/j.biomaterials.2018.03.054
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479